Georgetown Unversity Lombardi Comprehensive Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Georgetown Unversity Lombardi Comprehensive Cancer Center has participated in 1 clinical trials.
Therapeutic areas: Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma, Liver Cancer.
Sponsors: H3 Biomedicine Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Georgetown Unversity Lombardi Comprehensive Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Georgetown Unversity Lombardi Comprehensive Cancer Center has 1 clinical trials on record. Their work covers Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma, Liver Cancer.
Georgetown Unversity Lombardi Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.